CUSIP 690469101COMOVIDQ4 2025
52 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 10.71M | $17.46M |
| 2 | Affinity Asset Advisors, LLC | 7.15M | $11.65M |
| 3 | Eventide Asset Management, LLC | 4.29M | $6.98M |
| 4 | Adar1 Capital Management, LLC | 4.29M | $6.98M |
| 5 | Point72 Asset Management, L.P. | 3.55M | $5.79M |
| 6 | Adage Capital Partners Gp, L.L.C. | 3.49M | $5.69M |
| 7 | Federated Hermes, Inc. | 3.57M | $5.31M |
| 8 | Vanguard Group Inc | 3.07M | $5.01M |
| 9 |
| 4 | Jan 5, 2026 | Point72 Asset Management, L.P. | 13G | 5.1% | 6.73M | SEC |
| 5 | Dec 18, 2025 | Ra Capital Management, L.P. | 13G | 9.9% | 13.26M | SEC |
| 6 | Dec 18, 2025 | Affinity Asset Advisors, LLC | 13G | 9.0% | 12.15M | SEC |
| 7 | Dec 9, 2025 | Takeda Pharmaceutical Company Limited | 13G/A | 12.3% | 8.78M | SEC |
| 8 | Dec 8, 2025 | Janus Henderson Group PLC | 13G | 10.0% | 7.11M | SEC |
| 9 | Jul 21, 2025 | Biotechnology Value Fund L P | 13G/A | — | 212.0K | SEC |
| 10 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 1.9% | 1.37M | SEC |
See the full Schedule 13D/13G history for Ovid Therapeutics Inc.
Unlock full history| Saturn V Capital Management LP |
| 2.50M |
| $4.08M |
| 10 | Ally Bridge Group (Ny) LLC | 1.78M | $2.91M |